We are live on
!
Find out more
Allspring Global Investments Portfolio holdings
AUM
$59.7B
1-Year Est. Return
29.08%
This Fund
S&P 500
This Quarter
Est. Return
-1.62%
1 Year Est. Return
+29.08%
3 Year Est. Return
+84.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57.7B
AUM Growth
-$4.7B
(-7.5%)
Cap. Flow
-$2.64B
Cap. Flow
% of AUM
-4.58%
Top 10 Holdings %
Top 10 Hldgs %
12.87%
Holding
1,846
New
100
Increased
703
Reduced
859
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
D.R. Horton
DHI
|
+$230M |
| 2 |
APLU
Allspring Core Plus ETF
APLU
|
+$176M |
| 3 |
AINP
Allspring Income Plus ETF
AINP
|
+$158M |
| 4 |
AFIX
Allspring Broad Market Core Bond ETF
AFIX
|
+$145M |
| 5 |
CSX Corp
CSX
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBRE Group
CBRE
|
+$261M |
| 2 |
NVIDIA
NVDA
|
+$260M |
| 3 |
Salesforce
CRM
|
+$231M |
| 4 |
Allstate
ALL
|
+$200M |
| 5 |
TSMC
TSM
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Industrials | 14.63% |
| 3 | Financials | 13.82% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Healthcare | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Westlake Chemical Partners
WLKP
$778M
| $210K | ﹤0.01% |
9,100
| – | – |
|
|
TEF
1652
DELISTED
Telefonica
TEF
| $210K | ﹤0.01% |
44,817
+180
| +0.4% | +$772 |
|
|
SWTX
1653
DELISTED
SpringWorks Therapeutics
SWTX
| $208K | ﹤0.01% |
+4,711
| New | +$217K |
|
1654
Ameresco
AMRC
$1.47B
| $205K | ﹤0.01% |
16,964
+5,949
| +54% | +$108K |
|
1655
Voyager Therapeutics
VYGR
$197M
| $204K | ﹤0.01% |
60,462
+21,149
| +54% | +$98.8K |
|
1656
Ferguson
FERG
$47.4B
| $203K | ﹤0.01% |
1,278
-19,226
| -94% | -$3.33M |
|
1657
IonQ
IONQ
$18.3B
| $203K | ﹤0.01% |
8,735
+3,068
| +54% | +$99.4K |
|
1658
Ericsson
ERIC
$33.4B
| $196K | ﹤0.01% |
25,231
+1,713
| +7% | +$13.8K |
|
|
FOLD
1659
DELISTED
Amicus Therapeutics
FOLD
| $195K | ﹤0.01% |
24,530
+8,567
| +54% | +$79.3K |
|
1660
Woodside Energy
WDS
$43.6B
| $193K | ﹤0.01% |
13,313
+753
| +6% | +$11.5K |
|
1661
InMode
INMD
$875M
| $192K | ﹤0.01% |
+10,803
| New | +$195K |
|
1662
Fluence Energy
FLNC
$2.44B
| $184K | ﹤0.01% |
38,005
+13,427
| +55% | +$129K |
|
1663
Blue Owl Capital
OBDC
$5.75B
| $183K | ﹤0.01% |
+12,500
| New | +$188K |
|
1664
Daktronics
DAKT
$997M
| $181K | ﹤0.01% |
14,064
-993
| -7% | -$15K |
|
|
DIAX
1665
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
| $180K | ﹤0.01% |
+12,399
| New | +$187K |
|
1666
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
| $178K | ﹤0.01% |
1,107
-1,757
| -61% | -$287K |
|
1667
Rigetti Computing
RGTI
$6.15B
| $178K | ﹤0.01% |
+22,733
| New | +$252K |
|
1668
Inter&Co
INTR
$2.23B
| $170K | ﹤0.01% |
30,995
+14,971
| +93% | +$77.7K |
|
|
UNIT
1669
Uniti Group
UNIT
$2.31B
| $170K | ﹤0.01% |
32,531
+11,395
| +54% | +$61.5K |
|
1670
Zeta Global
ZETA
$7.17B
| $162K | ﹤0.01% |
+11,581
| New | +$207K |
|
1671
Clearway Energy Class C
CWEN
$7.06B
| $158K | ﹤0.01% |
5,200
+2,925
| +129% | +$79.5K |
|
1672
Relay Therapeutics
RLAY
$4.4B
| $157K | ﹤0.01% |
63,606
+22,307
| +54% | +$87.4K |
|
1673
Embecta
EMBC
$269M
| $154K | ﹤0.01% |
+12,181
| New | +$195K |
|
1674
iShares Core Dividend Growth ETF
DGRO
$43.8B
| $153K | ﹤0.01% |
2,485
-55,602
| -96% | -$3.48M |
|
1675
Entrada Therapeutics
TRDA
$299M
| $149K | ﹤0.01% |
17,020
+5,896
| +53% | +$73.5K |
|
Similar funds
QCM
NAMI
Allspring Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Allspring Global Investments held 1,846 positions worth $57.7B, down 7.5% from $62.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Allspring Global Investments withdrew a net $2.64B in Q1 2025, closing 118 positions and reducing 859 holdings. Its most notable exit was Huntsman Corp, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Industrials and Financials.
Against the trend, Allspring Global Investments opened a new position in Alnylam Pharmaceuticals worth $69.3M.
- Allspring Global Investments's largest Q1 2025 buy was Alnylam Pharmaceuticals: 270,924 shares worth $69.3M.
- Allspring Global Investments added most to D.R. Horton in Q1 2025, an estimated $230M increase.
- Allspring Global Investments's biggest Q1 2025 reduction was CBRE Group, cutting an estimated $261M.
- Allspring Global Investments fully exited Huntsman Corp in Q1 2025, selling an estimated $116M.
- Allspring Global Investments's ten largest holdings make up 13% of its $57.7B portfolio in Q1 2025.
- Allspring Global Investments opened 100 new positions and closed 118 in Q1 2025.
- Allspring Global Investments's portfolio value fell 7.5% quarter-over-quarter to $57.7B.
Based on Allspring Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.